Cardiotoxicity of Interferon*

Kirkwood, 1984, Interferons in the treatment of human cancer, J Clin Oncol, 2, 336, 10.1200/JCO.1984.2.4.336 Dickson, 1982, Death halts interferon trials in France, Science, 218, 772, 10.1126/science.6182613 Oldham, 1983, Toxic effects of interferon, Science, 219, 902, 10.1126/science.6186027 Sarna, 1983, Alpha (human leukocyte) interferon as treatment for non-small cell carcinoma of the lung: a phase H trial, J Biol Response Mod, 2, 343 Budd, 1984, Phase I trial of ultrapure human leukocyte interferon in human malignancy, Cancer Chemother Pharmacol, 12, 39 Foon, 1984, Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon, N Engl J Med, 311, 1148, 10.1056/NEJM198411013111803 Kirkwood, 1985, Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers, Ann Intern Med, 103, 32, 10.7326/0003-4819-103-1-32 Grunberg, 1985, Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma, Cancer Treat Rep, 69, 1031 Cooper, 1986, Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial, Cancer Treat Rep, 70, 473 Vadhan-Raj, 1986, Phase I trial of recombinant interferon gamma in cancer patients, J Clin Oncol, 4, 137, 10.1200/JCO.1986.4.2.137 Martino, 1987, Reversible arrhythmias observed in patients treated with recombinant alpha-2 interferon, J Cancer Res Clin Oncol, 113, 376, 10.1007/BF00397722 Cohen, 1988, Recombinant alpha-2 interferon related cardiomyopathy, Am J Med, 85, 549, 10.1016/S0002-9343(88)80094-9 Deyton, 1989, Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma, N Engl J Med, 321, 1246, 10.1056/NEJM198911023211806 Sonnenblick, 1990, Reversible interferon induced cardiomyopathy, Br Med J, 300, 1174, 10.1136/bmj.300.6733.1174 Ernstoff, 1987, A randomised phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma, J Clin Oncol, 5, 1804, 10.1200/JCO.1987.5.11.1804 Brown, 1987, A phase I clinical trial of recombinant DNA gamma interferon, J Clin Oncol, 5, 790, 10.1200/JCO.1987.5.5.790 Friess, 1989, Cardiovascular rhythm effects of gamma recombinant DNA interferon, Invest New Drugs, 7, 275, 10.1007/BF00170873 Sherwin, 1982, A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients, JAMA, 248, 2461, 10.1001/jama.1982.03330190025025 Rohatiner, 1982, A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion, Cancer Chemother Pharmacol, 9, 97, 10.1007/BF00265387 Smith, 1987, A phase I study of rDNA alpha-2b interferon as a 6-week continuous intravenous infusion, Cancer Chemother Pharmacol, 20, 327, 10.1007/BF00262586 Muss, 1985, A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy, Am J Clin Oncol, 8, 97, 10.1097/00000421-198504000-00001 Janssen, 1985, Phase I study of recombinant human interferon alpha-2C in patients with chemotherapy-refractory malignancies, Oncology, 42, 3, 10.1159/000226075 Sarna, 1985, Human alpha-lymphoblastoid interferon: a phase I study including pharmacokinetics and effects on hematologic stem cells (CFU-GMs), Am J Clin Oncol., 8, 406, 10.1097/00000421-198510000-00013 Wagstaff, 1984, A phase I toxicity study of human rDNA interferon in patients with solid tumors, Cancer Chemother Pharmacol, 13, 100, 10.1007/BF00257123 Edelstien, 1983, A phase I clinical tolerance study of rDNA alpha 2 human interferon in patients with non-reticuloendothelial system malignancies, Eur J Cancer Clin Oncol, 19, 891, 10.1016/0277-5379(83)90053-6 Garnick, 1988, Phase I/II study of recombinant interferon gamma in advanced renal cell carcinoma, J Urol, 139, 251, 10.1016/S0022-5347(17)42379-2 Perez, 1988, A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy, J Biol Response Mod, 7, 309 Kurzrock, 1986, Phase I study of multiple dose intramuscularly administered recombinant gamma interferon, J Clin Oncol, 4, 1101, 10.1200/JCO.1986.4.7.1101 Vadhan-Raj, 1986, Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion, Cancer Treat Rep, 70, 609 Foon, 1985, A phase I trial of recombinant gamma interferon in patients with cancer, Cancer Immunol Immunother, 20, 193, 10.1007/BF00205575 Sarna, 1986, Phase I study of recombinant beta ser 17 interferon in the treatment of cancer, Cancer Treat Rep, 70, 1365 Borden, 1988, Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial, J Interferon Res, 8, 357, 10.1089/jir.1988.8.357 Borden, 1988, Effects of interferon in neoplastic diseases of man, Pharmacol Ther, 37, 213, 10.1016/0163-7258(88)90026-5 Lampidis, 1981, Interferon inhibits cardiac cell function in vitro (41043), Proc Soc Exp Biol Med, 166, 181, 10.3181/00379727-166-41043 Bialock, 1980, Common pathways of interferon and hormonal action, Nature, 283, 406, 10.1038/283406a0